the sun malaysia ipaper logo 150x150
Friday, July 3, 2026
27.5 C
Kuala Lumpur
the sun malaysia ipaper logo 150x150

Post-mortem on Malaysian climber on June 3

KUALA LUMPUR: The body of climber, Zulkifli Yusuf, currently in a hospital in Anchorage, Alaska, is scheduled to undergo a post-mortem on Monday (June 3).

The Alpine Club Malaysia said this, via a Facebook post, today.

“Once the post-mortem is completed, the next process is to obtain the necessary documents for the repatriation of the body to Malaysia, with the help of the Malaysian consulate-general in Los Angeles and the insurance company,” it said.

ALSO READ: Remains of M’sian climber brought down from Mount Denali

It also said that climber, Zainudin Lot’s health condition was getting better, and he was discharged from the hospital in Talkeetna, Alaska on Sunday.

“Meanwhile, Muhammad Illaham Ishak is still undergoing treatment at the hospital in Anchorage. Alpine Club representative, Nor Safrina Shamsir Md Nasir, who is currently in Talkeetna, Alaska, will assist with the matter of taking the hiking equipment, currently still in Mount Denali, which needs to be removed by the Denali National Park authorities,” read the post.

For any information contact the club liaison officer, Ayob Yahaya, at 017 337 2696.

Yesterday, the Alpine Club Malaysia said that the body of the late Zulkifli Yusof, 37, who died after being stranded at the height of 19,700ft, on Mount Denali in Alaska, was brought down at 8.30 am (local time), on June 1.

READ MORE: Malaysian climber rescued, another perishes on Alaskan mountain

STAY AHEAD OF THE CURVE

Join our community for instant updates and exclusive content.

Join Telegram Channel

Related


spot_img

Latest News

Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations

TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced the completion of its acquisition of the GMP manufacturing operations of MacroGenics, Inc. (NASDAQ: MGNX) including its biologics drug substance facility in Rockville, Maryland and an associated warehousing center in Frederick, Maryland, for total consideration of US $122.5 million through its wholly owned subsidiary Bora Biologics USA, LLC.. Upon closing, Bora signed a long-term CDMO Service Agreement with MacroGenics.

Most Viewed

spot_img
WC26

World Cup 2026

Updates, Fixtures, Results & Standings